-Reuven Mader Researcher Activity Profile

Research Author Detailed Information 

Reuven Mader Publication Rate By Year

Reuven Mader has published 7 paper(s) in 2007, 1 paper(s) in 2008, for a total of 8 research publications in total.

Reuven R Mader Author Information

LAST NAME: mader

FIRST NAME: reuven

INITIALS: R

AFFILIATION:

Papers

Reuven Mader's Publication Record

1. Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity. Year Published: 2007
Department of Medicine D, Ha'Emek Medical Center, Afula 18101, Israel.
2. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Year Published: 2007
Rheumatic Disease Unit, Ha'emek Medical Center, Afula, 18101, Israel. Mader_r@clalit.org.il
3. Optimizing treatment with biologics. Year Published: 2007
From the Rebecca McDonald Centre for Arthritis and Autoimmune Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
4. Optimizing treatment with biologics. Year Published: 2007
Rebecca McDonald Centre for Arthritis and Autoimmune Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
5. Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity. Year Published: 2007
Department of Medicine D, Ha'Emek Medical Center, Afula 18101, Israel.
6. Optimizing treatment with biologics. Year Published: 2007
Rebecca McDonald Centre for Arthritis and Autoimmune Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
7. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Year Published: 2007
Rheumatic Disease Unit, Ha'emek Medical Center, Afula, 18101, Israel. Mader_r@clalit.org.il
8. Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. Year Published: 2008
Can-Fite BioPharma Ltd, Petach Tikva, Israel.